06-11-2024 |
PM |
|
CRL |
Charles River Laboratories International, Inc. |
9,420 |
2.59 |
2.43 |
2.72 |
Charles River Laboratories Non-GAAP EPS of $2.59 beats by $0.17, revenue of $1.01B beats by $34.5M [11/6/2024 7:13 AM] |
213.51 |
24.83 (13.16%) |
215.00 |
26.32 (13.95%) |
166.87 - 275.00 |
1,986,915 |
750,000 |
9,830 |
|
|
07-08-2024 |
PM |
|
CRL |
Charles River Laboratories International, Inc. |
12,030 |
2.80 |
2.39 |
2.69 |
Charles River Laboratories beats top-line and bottom-line estimates; lowers FY24 outlook [8/7/2024 7:10 AM] |
199.42 |
-29.38 (-12.84%) |
192.00 |
-36.80 (-16.08%) |
161.65 - 275.00 |
3,592,305 |
700,000 |
130,930 |
|
|
09-05-2024 |
PM |
|
CRL |
Charles River Laboratories International, Inc. |
12,130 |
2.27 |
2.05 |
2.78 |
Charles River Laboratories Non-GAAP EPS of $2.27 beats by $0.21, revenue of $1.01B beats by $16.54M [5/9/2024 7:14 AM] |
230.30 |
-4.99 (-2.12%) |
229.00 |
-6.29 (-2.67%) |
161.65 - 275.00 |
802,776 |
480,000 |
200 |
|
|
14-02-2024 |
PM |
|
CRL |
Charles River Laboratories International, Inc. |
11,580 |
2.46 |
2.39 |
2.98 |
Charles River Laboratories Non-GAAP EPS of $2.46 beats by $0.06, revenue of $1.01B beats by $18.75M [2/14/2024 7:17 AM] |
245.21 |
24.97 (11.34%) |
228.10 |
7.86 (3.57%) |
161.65 - 257.17 |
1,452,722 |
500,000 |
16,276 |
|
|
08-11-2023 |
PM |
|
CRL |
Charles River Laboratories International, Inc. |
9,300 |
2.72 |
2.35 |
2.63 |
Charles River Laboratories Non-GAAP EPS of $2.72 beats by $0.35, revenue of $1.03B beats by $30M [11/8/2023 7:01 AM] |
175.89 |
-6.92 (-3.79%) |
179.00 |
-3.81 (-2.08%) |
161.65 - 262.00 |
867,915 |
710,000 |
727 |
|
|
09-08-2023 |
PM |
|
CRL |
Charles River Laboratories International, Inc. |
10,510 |
2.69 |
2.63 |
2.77 |
Charles River Laboratories beats Q2 top and bottom line estimates; raises FY23 outlook [8/9/2023 7:07 AM] |
215.33 |
9.09 (4.41%) |
212.00 |
5.76 (2.79%) |
181.22 - 262.00 |
817,829 |
460,000 |
11,838 |
|
|
11-05-2023 |
PM |
7:00 AM ET (May 11) |
CRL |
Charles River Laboratories International, Inc. |
9,600 |
2.78 |
2.59 |
2.75 |
Charles River Laboratories Non-GAAP EPS of $2.78 beats by $0.19, revenue of $1.03B beats by $43.94M [5/11/2023 7:02 AM] |
195.49 |
9.19 (4.93%) |
190.23 |
3.93 (2.11%) |
181.22 - 262.00 |
1,051,921 |
530,000 |
3,683 |
|
|
22-02-2023 |
PM |
7:00 AM ET (Feb 22) |
CRL |
Charles River Laboratories International, Inc. |
12,940 |
2.98 |
2.75 |
2.49 |
Charles River Laboratories beats Q4 top and bottom line estimates; initiates FY23 outlook [2/22/2023 7:02 AM] |
217.85 |
-25.75 (-10.57%) |
215.00 |
-28.60 (-11.74%) |
181.36 - 308.15 |
2,062,676 |
540,000 |
14,817 |
|
|
02-11-2022 |
PM |
7:00 AM ET (Nov 2) |
CRL |
Charles River Laboratories International, Inc. |
10,800 |
2.63 |
2.51 |
2.70 |
Charles River Laboratories Non-GAAP EPS of $2.63 beats by $0.13, revenue of $989.2M beats by $18.77M, updates FY guidance [11/2/2022 7:10 AM] |
216.35 |
9.06 (4.37%) |
211.00 |
3.71 (1.79%) |
181.36 - 441.91 |
1,063,582 |
640,000 |
154 |
|
|
03-08-2022 |
PM |
7:00 AM ET (Aug 3) |
CRL |
Charles River Laboratories International, Inc. |
12,040 |
2.77 |
2.74 |
2.61 |
|
222.01 |
-21.65 (-8.89%) |
243.66 |
0.0 (0.00%) |
203.37 - 460.21 |
1,626,374 |
470,000 |
3,767 |
|
|
04-05-2022 |
PM |
7:00 AM ET (May 4) |
CRL |
Charles River Laboratories International |
12,193 |
2.75 |
2.71 |
0.00 |
Charles River Laboratories Non-GAAP EPS of $2.75 beats by $0.03, revenue of $913.9M beats by $5.26M; updates FY22 guidance [5/4/2022 7:05 AM] |
258.39 |
7.20 (2.87%) |
251.19 |
0.0 (0.00%) |
230.62 - 460.21 |
895,200 |
780,000 |
2,599 |
|
|
16-02-2022 |
PM |
7:00 AM ET (Feb 16) |
CRL |
Charles River Laboratories International, Inc. |
16,520 |
2.49 |
2.42 |
2.39 |
Charles River Laboratories Non-GAAP EPS of $2.49 beats by $0.06, revenue of $905.05M beats by $16.78M [2/16/2022 7:05 AM] |
305.74 |
-6.89 (-2.20%) |
301.00 |
-11.63 (-3.72%) |
259.02 - 460.21 |
1,100,299 |
450,000 |
9,541 |
|
|
03-11-2021 |
PM |
7:00 AM ET (Nov 3) |
CRL |
Charles River Laboratories International, Inc. |
22,190 |
2.70 |
2.57 |
2.33 |
Charles River Laboratories EPS beats by $0.12, misses on revenue [11/3/2021 7:09 AM] |
387.93 |
-44.02 (-10.19%) |
400.00 |
-31.95 (-7.40%) |
224.06 - 460.21 |
1,589,047 |
270,000 |
816 |
|
|
04-08-2021 |
PM |
7:00 AM ET (Aug 4) |
CRL |
Charles River Laboratories International, Inc. |
20,380 |
2.61 |
2.39 |
1.58 |
Charles River Laboratories EPS beats by $0.23, beats on revenue [8/4/2021 7:15 AM] |
416.31 |
5.07 (1.23%) |
416.31 |
0.0 (0.00%) |
197.33 - 420.25 |
457,909 |
280,000 |
3,132 |
|
|
04-05-2021 |
PM |
7:10 AM ET (May 4) |
CRL |
Charles River Laboratories International, Inc. |
16,760 |
2.53 |
2.19 |
1.84 |
Charles River Laboratories EPS beats by $0.34, beats on revenue [5/4/2021 7:16 AM] |
338.96 |
7.01 (2.11%) |
338.96 |
0.0 (0.00%) |
136.00 - 343.47 |
650,978 |
300,000 |
1,786 |
|
|
17-02-2021 |
PM |
7:00 AM ET (Feb 17) |
CRL |
Charles River Laboratories International, Inc. |
14,560 |
2.39 |
2.12 |
2.01 |
Charles River Laboratories EPS beats by $0.28, beats on revenue [2/17/2021 7:10 AM] |
299.74 |
13.00 (4.54%) |
286.74 |
0.0 (0.00%) |
95.58 - 303.79 |
666,319 |
313,661 |
12,926 |
|
|
29-10-2020 |
PM |
7:00 AM ET (Oct 29) |
CRL |
Charles River Laboratories International, Inc. |
11,570 |
2.33 |
1.80 |
1.69 |
Charles River Laboratories EPS beats by $0.53, beats on revenue [10/29/2020 7:09 AM] |
228.94 |
6.94 (3.13%) |
222.00 |
0.0 (0.00%) |
95.58 - 250.29 |
574,556 |
347,313 |
88,649 |
|
|
05-08-2020 |
PM |
7:00 AM ET (Aug 5) |
CRL |
Charles River Laboratories International, Inc. |
9,850 |
1.58 |
1.27 |
1.63 |
Charles River Laboratories EPS beats by $0.30, beats on revenue [8/5/2020 7:15 AM] |
215.06 |
11.14 (5.46%) |
203.92 |
0.0 (0.00%) |
95.58 - 216.68 |
314,708 |
282,030 |
6,441 |
|
|